- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01995994
Continuous Glucose Monitoring System in Intensive Care Unit
May 19, 2015 updated by: Jin-Tae Kim, Seoul National University Hospital
Continuous Glucose Monitoring System in Intensive Care Unit - Preliminary Study Evaluating Accuracy
To assess the accuracy, safety, and influence of sampling site of Real-time continuous glucose monitoring system (Medtronic Guardian).
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
23
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 110-744
- Seoul National University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients planned to stay in intensive care units longer than 72 hours
Description
Inclusion Criteria:
- Older than 18 years old
- Staying in intensive care units longer than 72 hours
Exclusion Criteria:
- Skin disease
- DIC
- Immune suppressed patients
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
RT-CGM
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Difference between finger stick blood glucose and real-time continuous glucose monitoring
Time Frame: 72 hours
|
72 hours
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Measurement error of real-time continuous glucose monitoring
Time Frame: 72 hours
|
72 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jin-Tae Kim, MD. PhD., Seoul National University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2012
Primary Completion (Actual)
November 1, 2013
Study Completion (Actual)
February 1, 2014
Study Registration Dates
First Submitted
November 21, 2013
First Submitted That Met QC Criteria
November 26, 2013
First Posted (Estimate)
November 27, 2013
Study Record Updates
Last Update Posted (Estimate)
May 21, 2015
Last Update Submitted That Met QC Criteria
May 19, 2015
Last Verified
November 1, 2013
More Information
Terms related to this study
Other Study ID Numbers
- D-1203-106-404
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetic Blood Glucose Monitoring
-
Efforia, IncCompleted
-
Wrocław University of Science and TechnologyT. Marciniak Lower Silesian Specialist Hospital in WrocławNot yet recruiting
-
Charite University, Berlin, GermanyCompletedGlucose Metabolism Disorders | Critical Illness | Diabetic Blood Glucose MonitoringGermany
-
HealthPartners InstituteAbbott Diabetes CareCompletedContinuous Glucose Monitoring Self-Monitored Blood Glucose Type 2 Therapy Matrix Definition (REACT4)Diabetes Mellitus, Type 2 | Diabetic Blood Glucose MonitoringUnited States
-
GlySureKentronUnknownBlood Glucose Monitoring in Medical ICU
-
OptiScan Biomedical CorporationUnknownICU/CCU Patients Requiring Blood Glucose MonitoringUnited States
-
Hospital de Clinicas de Porto AlegreUnknownDiabetes Mellitus, Type 2 | Exercise | Hypoglycemic Agents | Diabetic Blood Glucose MonitoringBrazil
-
Edwards LifesciencesMedPass International; 95 bis boulevard Pereire; 75017 Paris - FranceCompletedAccurate Blood Glucose Monitoring in Critical Care SettingAustria, Belgium
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do Sul; Coordenação de Aperfeiçoamento de...CompletedDiabetes Mellitus Type 2 | Dietary Modification | Insulin Tolerance | Diabetic Blood Glucose MonitoringBrazil